<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Medical Diagnostics Articles in Medical XPRT</title><link>https://alpha.medical-xprt.com/medical-diagnostics/articles</link><description>Medical Diagnostics Articles in Medical XPRT</description><image><url>https://alpha.medical-xprt.com/images/logo.gif</url><link>https://alpha.medical-xprt.com/medical-diagnostics/articles</link><title>Medical Diagnostics Articles in Medical XPRT</title></image><item><title>Al Sandrock notches another post-Biogen role — and it`s taking him right back onto familiar ground</title><link>https://alpha.medical-xprt.com/articles/al-sandrock-notches-another-post-biogen-role-and-it-s-taking-him-right-back-onto-familiar-ground-1096912</link><description><![CDATA[Al Sandrock has landed another post-Biogen gig for this next chapter in his biotech career following the catastrophic collapse of his campaign for Aduhelm.  The R&amp;D expert has lined up a board post for Verge Genomics, an AI-powered startup that has its sights set on a drug program for ALS, followed by new work on Parkinson&rsquo;s &mdash; putting the CNS-focused Sandrock right back into a research arena, where he has fought many, many times before.      https://endpts.com/al-sandrock-notches-another-post-biogen-role-and-its-taking-him-right-back-onto-familiar-ground/      ]]></description><pubDate>Tue, 08 Feb 2022 00:00:00 +0000</pubDate><guid>https://alpha.medical-xprt.com/articles/al-sandrock-notches-another-post-biogen-role-and-it-s-taking-him-right-back-onto-familiar-ground-1096912</guid><category>genomics</category></item></channel></rss>
